Protalix BioTherapeutics (PLX) Net Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.72% |
| Dec 31, 2025 | -73.14% |
| Sep 30, 2025 | 20.40% |
| Jun 30, 2025 | 15.93% |
| Mar 31, 2025 | -34.93% |
| Dec 31, 2024 | 149.84% |
| Sep 30, 2024 | 23.73% |
| Jun 30, 2024 | 22.23% |
| Mar 31, 2024 | 9.22% |
| Dec 31, 2023 | -34.95% |
| Sep 30, 2023 | 19.71% |
| Jun 30, 2023 | 31.28% |
| Mar 31, 2023 | 15.74% |
| Dec 31, 2022 | 21.10% |
| Jun 30, 2021 | -149.75% |
| Mar 31, 2021 | -141.06% |
| Dec 31, 2020 | -67.02% |
| Sep 30, 2020 | -32.44% |
| Jun 30, 2020 | -41.96% |
| Mar 31, 2020 | 22.03% |
| Mar 31, 2019 | -0.19% |
| Dec 31, 2018 | 20.20% |
| Sep 30, 2018 | 0.33% |
| Jun 30, 2018 | -4.37% |
| Mar 31, 2018 | -10.65% |
| Dec 31, 2017 | -0.64% |
| Jun 30, 2016 | 61.52% |
| Mar 31, 2016 | 57.24% |
| Dec 31, 2015 | 62.15% |
| Sep 30, 2015 | 22.61% |
| Jun 30, 2015 | 16.10% |